These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 120167)

  • 21. Early protection by vaccines against Pseudomonas aeruginosa colonizing burns.
    Jones RJ; Lowbury EJ
    Br J Exp Pathol; 1972 Dec; 53(6):659-64. PubMed ID: 4630411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study.
    Baumann U; Göcke K; Gewecke B; Freihorst J; von Specht BU
    Respir Res; 2007 Aug; 8(1):57. PubMed ID: 17683588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and immunogenicity of an oral inactivated whole-cell pseudomonas aeruginosa vaccine administered to healthy human subjects.
    Cripps AW; Peek K; Dunkley M; Vento K; Marjason JK; McIntyre ME; Sizer P; Croft D; Sedlak-Weinstein L
    Infect Immun; 2006 Feb; 74(2):968-74. PubMed ID: 16428742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pseudomonas aeruginosa vaccine in cancer patients.
    Young LS; Meyer RD; Armstrong D
    Ann Intern Med; 1973 Oct; 79(4):518-27. PubMed ID: 4201225
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunogenic properties of a polyvalent vaccine against Pseudomonas aeruginosa].
    Serafińska D; Bukowska D; Sokołowska K; Nasiłowski W
    Pol Tyg Lek; 1980 Jul; 35(27):1013-5. PubMed ID: 6775310
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunological evaluation of an alginate-based conjugate as a vaccine candidate against Pseudomonas aeruginosa.
    Farjah A; Owlia P; Siadat SD; Mousavi SF; Ardestani MS; Mohammadpour HK
    APMIS; 2015 Feb; 123(2):175-83. PubMed ID: 25470757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Passive protection of mice against Pseudomonas aeruginosa by serum from recently vaccinated mice.
    Jones RJ; Lilly HA; Lowbury EJ
    Br J Exp Pathol; 1971 Jun; 52(3):264-70. PubMed ID: 4996963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of pseudomonas respiratory infection in a surgical intensive care unit.
    Polk HC; Borden S; Aldrete JA
    Ann Surg; 1973 May; 177(5):607-15. PubMed ID: 4634109
    [No Abstract]   [Full Text] [Related]  

  • 29. 40 years on: have we finally got a vaccine for Pseudomonas aeruginosa?
    Worgall S
    Future Microbiol; 2012 Dec; 7(12):1333-5. PubMed ID: 23231481
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experimental infection of immunized mice homologous and heterologous serotypes with Pseudomonas aeruginosa].
    Vidal G; Mynard MC
    Ann Inst Pasteur (Paris); 1972 Jun; 122(6):1129-35. PubMed ID: 4627762
    [No Abstract]   [Full Text] [Related]  

  • 31. Controlled prospective trial of Pseudomonas aeruginosa vaccine in children with acute leukemia.
    Haghbin M; Armstrong D; Murphy ML
    Cancer; 1973 Oct; 32(4):761-6. PubMed ID: 4201654
    [No Abstract]   [Full Text] [Related]  

  • 32. Investigations on the efficacy of specific immunization with corpuscular vaccines in urinary tract infections with Pseudomonas aeruginosa or mixed bacteria.
    Neagu V; Meitert E; Ioanid CP; Racovită C; Găleşanu M; Sima F; Savulian C; Momiceanu D; Noica N; Neagoe M
    Arch Roum Pathol Exp Microbiol; 1984; 43(1):39-52. PubMed ID: 6442131
    [No Abstract]   [Full Text] [Related]  

  • 33. [Specificity of antimicrobial immunity in experimental infection with strains of Pseudomonas aeruginosa].
    Akatova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Sep; (9):89-93. PubMed ID: 65079
    [No Abstract]   [Full Text] [Related]  

  • 34. [Results of using a polyvalent vaccine against Pseudomonas aeruginosa in patients with burns treated at various therapeutic centers in Poland].
    Bukowska D; Serafińska D; Zietkiewicz W; Rudowski W; Hoffman S; Uszyński H; Molski M; Hess C; Jonecko A; Popiel D
    Pol Tyg Lek; 1986 Dec; 41(49):1549-52. PubMed ID: 3108869
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevention of Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Döring G
    Int J Med Microbiol; 2010 Dec; 300(8):573-7. PubMed ID: 20940108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current status of experimental studies on Pseudomonas aeruginosa infection].
    Honma Y
    Nihon Saikingaku Zasshi; 1972 Sep; 27(5):629-40. PubMed ID: 4199828
    [No Abstract]   [Full Text] [Related]  

  • 37. Active and passive immunity against Pseudomonas aeruginosa with a ribosomal vaccine and antiserum in C3H/HeJ mice.
    Lieberman MM; Ayala E
    J Immunol; 1983 Jul; 131(1):1-3. PubMed ID: 6408166
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunity to Pseudomonas aeruginosa induced by OprF following intestinal immunization.
    Cripps AW; Dunkley ML; Taylor DC; Cousins S; Clancy RL
    Adv Exp Med Biol; 1995; 371B():761-3. PubMed ID: 7502893
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pseudomonas aeruginosa preparations for active immunization].
    Nazarchuk LV
    Vrach Delo; 1991 Jul; (7):22-7. PubMed ID: 1771827
    [No Abstract]   [Full Text] [Related]  

  • 40. Multivalent DNA vaccine protects mice against pulmonary infection caused by Pseudomonas aeruginosa.
    Saha S; Takeshita F; Sasaki S; Matsuda T; Tanaka T; Tozuka M; Takase K; Matsumoto T; Okuda K; Ishii N; Yamaguchi K; Klinman DM; Xin KQ; Okuda K
    Vaccine; 2006 Sep; 24(37-39):6240-9. PubMed ID: 16806598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.